Anti-Cancer Drug Sensitivity Assay with Quantitative Heterogeneity Testing Using Single-Cell Raman Spectroscopy

A novel anti-cancer drug sensitivity testing (DST) approach was developed based on in vitro single-cell Raman spectrum intensity (RSI). Generally, the intensity of Raman spectra (RS) for a single living cell treated with drugs positively relates to the sensitivity of the cells to the drugs. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Xu, Jingjing, Yu, Yuezhou, Shang, Wenhao, Ye, Anpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278387/
https://www.ncbi.nlm.nih.gov/pubmed/30405051
http://dx.doi.org/10.3390/molecules23112903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278387/
https://www.ncbi.nlm.nih.gov/pubmed/30405051
http://dx.doi.org/10.3390/molecules23112903

Ejemplares similares